Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim F Greten

Showing results (131-140 of 223) with videos related to

Pageof 23
Sort By:
Cancer Immunology, Immunotherapy : CII|July 1, 2018
Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinomaZachary J Brown, Su Jong Yu, Bernd Heinrich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
Necrotic tumor cell death in vivo impairs tumor-specific immune responsesJaba Gamrekelashvili, Christine Krüger, Reinhard von Wasielewski, et al.
World Journal of Gastroenterology|May 24, 2006
Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinomaLars-A Ormandy, Anatol Farber, Tobias Cantz, et al.
Annals of Surgery|October 16, 2020
Transplant Oncology in Primary and Metastatic Liver Tumors: Principles, Evidence, and OpportunitiesGonzalo Sapisochin, Taizo Hibi, Christian Toso, et al.
Scandinavian Journal of Gastroenterology|June 23, 2011
Epidemiological trends in incidence and mortality of hepatobiliary cancers in GermanyThomas von Hahn, Sandra Ciesek, Gerd Wegener, et al.
Nature Reviews. Gastroenterology & Hepatology|March 18, 2023
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatmentJosep M Llovet, Catherine E Willoughby, Amit G Singal, et al.
Cancer|March 22, 2016
Population attributable fractions of risk factors for hepatocellular carcinoma in the United StatesOxana V Makarova-Rusher, Sean F Altekruse, Tim S McNeel, et al.
Hepatic Oncology|February 17, 2015
Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decadesSusanna V Ulahannan, Osama E Rahma, Austin G Duffy, et al.
Iscience|February 24, 2022
NAFLD indirectly impairs antigen-specific CD8<sup>+</sup> T cell immunity against liver cancer in miceJohn C McVey, Benjamin L Green, Benjamin Ruf, et al.
Frontiers in Immunology|July 14, 2022
Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular CarcinomaBernd Heinrich, Benjamin Ruf, Varun Subramanyam, et al.
Pageof 23

Showing results (131-140 of 223) with videos related to

Sort By:
Pageof 23
Cancer Immunology, Immunotherapy : CII|July 1, 2018
Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinomaZachary J Brown, Su Jong Yu, Bernd Heinrich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
Necrotic tumor cell death in vivo impairs tumor-specific immune responsesJaba Gamrekelashvili, Christine Krüger, Reinhard von Wasielewski, et al.
World Journal of Gastroenterology|May 24, 2006
Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinomaLars-A Ormandy, Anatol Farber, Tobias Cantz, et al.
Annals of Surgery|October 16, 2020
Transplant Oncology in Primary and Metastatic Liver Tumors: Principles, Evidence, and OpportunitiesGonzalo Sapisochin, Taizo Hibi, Christian Toso, et al.
Scandinavian Journal of Gastroenterology|June 23, 2011
Epidemiological trends in incidence and mortality of hepatobiliary cancers in GermanyThomas von Hahn, Sandra Ciesek, Gerd Wegener, et al.
Nature Reviews. Gastroenterology & Hepatology|March 18, 2023
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatmentJosep M Llovet, Catherine E Willoughby, Amit G Singal, et al.
Cancer|March 22, 2016
Population attributable fractions of risk factors for hepatocellular carcinoma in the United StatesOxana V Makarova-Rusher, Sean F Altekruse, Tim S McNeel, et al.
Hepatic Oncology|February 17, 2015
Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decadesSusanna V Ulahannan, Osama E Rahma, Austin G Duffy, et al.
Iscience|February 24, 2022
NAFLD indirectly impairs antigen-specific CD8<sup>+</sup> T cell immunity against liver cancer in miceJohn C McVey, Benjamin L Green, Benjamin Ruf, et al.
Frontiers in Immunology|July 14, 2022
Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular CarcinomaBernd Heinrich, Benjamin Ruf, Varun Subramanyam, et al.
Pageof 23